Food Allergy and Your Kiddo podcast

Xolair or OIT? The better option is...

0:00
25:17
Reculer de 15 secondes
Avancer de 15 secondes

What topic would you like discussed? Text us!

The headlines makes it sound simple: omalizumab (Xolair) performs as well as or better than multi-food oral immunotherapy for food allergy. But once you look under the hood, the story gets a lot more nuanced and a lot more real. Fresh from the AAAAI 2026 conference, I walk you through what the new data actually show, why the study design isn't ideal, and what parents should ask their allergist before choosing a path, whether that be with Xolair, OIT, SLIT, or avoidance.

Link to the articles I mention:

Food Allergy Peds Hub: https://foodallergypedshub.hoytallergy.com/newsletters/the-food-allergy-friday-newsletter/posts/is-xolair-superior-to-oit

Doximity: https://opmed.doximity.com/articles/aaaai-2026-good-science-great-connections

If this helps you think more clearly about your child's food allergy treatment, subscribe, share the episode with a friend, and leave a review so more families can find it.

Resources

📖 Navigating Food Allergies: A Parent’s Guide to Care, Coverage, and Confidence by Dr. Alice Hoyt - preorder from Amazon and more 

For Parents ➡️ Office Hours for Parents 

For Providers ➡️ Food Allergy Pediatric Hub

For Schools ➡️ Code Ana

For Potential Patients ➡️ Hoyt Institute of Food Allergy

🔎 Find an Allergist
AAAAI Allergist Finder
ACAAI Allergist Finder
OIT Allergist Finder

This podcast is the official podcast of the Hoyt Institute of Food Allergy. Information on, within, and associated with this site and Food Allergy and Your Kiddo is for educational purposes only and is not medical advice.

D'autres épisodes de "Food Allergy and Your Kiddo"